Aug 3, 2026 06:31AM

Aug 3, 2026 06:31AM

Aug 3, 2026 06:30AM

Mar 31, 2026 09:00AM

Feb 26, 2026 07:00AM

Oct 30, 2025 07:00AM

Jul 31, 2025 07:00AM Indivior Reports Second Quarter 2025 Financial Results and Raises FY 2025 Financial Guidance

Jun 24, 2025 04:13PM

Jun 24, 2025 04:12PM

Oct 31, 2023 09:00AM

May 22, 2023 07:40PM

Mar 2, 2023 10:14AM

Feb 7, 2023 04:02PM

Feb 7, 2023 04:01PM Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC

Feb 6, 2023 08:00AM

Dec 7, 2022 02:30AM

Nov 20, 2022 08:46AM

Nov 14, 2022 02:12AM

Nov 14, 2022 02:10AM

Jul 24, 2020 10:35AM

Jun 24, 2020 08:30AM New Data from the RECOVER™ Study Reveal Two-Year Outcomes in People with Opioid Use Disorder Following Transition from Pivotal Phase 3 Clinical Trials to a Real-World Setting

Mar 23, 2020 08:00AM

Dec 10, 2019 09:30AM

Dec 2, 2019 08:00AM

Nov 11, 2019 12:43PM

Sep 26, 2019 03:19PM

Jun 17, 2019 02:43PM

Apr 9, 2019 06:01PM Statement of Indivior on Grand Jury Indictment

Apr 6, 2019 08:36AM

Apr 5, 2019 08:36AM

Mar 7, 2019 10:30AM

Feb 27, 2019 08:06AM

Feb 20, 2019 09:37AM

Feb 19, 2019 08:00AM

Dec 20, 2018 09:00AM Indivior Publishes Design and Patient Characteristics for Real-World Study of Life Changes in People Treated with SUBLOCADE™ (Buprenorphine Extended-Release) in Contemporary Clinical Trials

Nov 27, 2018 08:00AM

Nov 23, 2018 09:56AM

Nov 21, 2018 09:30AM

Nov 19, 2018 08:06AM

Nov 1, 2018 07:26AM

Oct 24, 2018 02:32PM

Sep 26, 2018 11:57AM Indivior Provides Update on Key Business Drivers and Expectations

Jul 31, 2018 08:03AM

Jul 27, 2018 07:44PM

Jul 13, 2018 06:22PM

Jul 11, 2018 07:47AM

Jun 28, 2018 06:07PM

Jun 15, 2018 08:00PM

Jun 15, 2018 10:11AM Indivior Responds to Generic SUBOXONE® Approvals and Dr. Reddy's Launch "At-Risk"

May 31, 2018 08:45AM

1,178,221 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All